Educational posts about parathyroid surgery, including when surgery is considered, what patients can expect, and factors that may influence surgical decision-making.

What Tests Do I Really Need Before I Decide on Parathyroid Surgery?

/in , /by

Patients often ask this question after they learn their calcium is high. That is the right question. The answer is that the decision almost always starts with the lab work, but it should also include the patient’s symptoms and any signs that the disease may already be affecting the kidneys, bones, or other organs. Primary hyperparathyroidism is fundamentally a biochemical diagnosis. Imaging and additional studies can be helpful, but they do not make the diagnosis.

1. The most important tests are the calcium and PTH levels.
In most cases, the key decision point comes from the blood work. If the calcium is high and the parathyroid hormone level is also high, or “inappropriately normal” when it should be suppressed, that is the central evidence for primary hyperparathyroidism. In many patients, those labs already make the diagnosis clear enough that surgery can be discussed seriously right away. The scan does not make that decision. The blood work does. You will note that ultrasounds and Sestamibi scans are not even mentioned in this article. These scans really are only utilized in planning an operation and need not be done prior to that.

2. Symptoms matter, even when they are subjective.
Not every patient presents with kidney stones or obvious osteoporosis. Many patients come in because they feel tired, foggy, run down, achy, anxious, or just not quite themselves. These symptoms are not always easy to measure, but they are still part of the decision-making. They often fit with what we see in patients with hyperparathyroidism. When the lab findings are convincing and the patient is having symptoms that may reasonably be related to high calcium, that often strengthens the case for surgery even if no other test has yet been done. Current guidelines note that neurocognitive and quality-of-life symptoms are recognized clinically, even though they are not always used as strict formal criteria the same way kidney or bone findings are.

3. Additional testing can show whether the disease is already affecting the body.
Once the diagnosis looks likely, the next question is whether the hyperparathyroidism may already be causing systemic problems. That is where tests such as kidney function, kidney imaging, 24-hour urine calcium, and bone density can become useful. A history of kidney stones, silent stones seen on imaging, reduced kidney function, or bone loss on DEXA all strengthen the argument that the disease is not just a lab abnormality. These findings are well-established reasons to recommend surgery.

4. In most patients, these extra tests do not determine whether surgery is needed. They help show how far the disease has progressed.
This is an important practical point. In many patients, the calcium and PTH pattern is already convincing enough, and the overall picture already supports surgery without waiting for a 24-hour urine calcium or a bone density test. Those tests are still worthwhile because they can document whether there has already been progression to kidney or bone involvement. But in most straightforward cases, they do not change the overall recommendation for surgery. They add information, more than changing the basic conclusion.

5. Borderline cases are where the extra testing can matter most.
When the labs are only mildly abnormal, the additional studies can help move the decision one way or the other. For example, a patient with only modest calcium elevation but a history of kidney stones and high urinary calcium may look very different once that full picture is known. Likewise, a patient with borderline lab findings who already shows osteopenia or osteoporosis on DEXA may have a stronger reason to move toward surgery sooner rather than later. Current guidance includes renal stones, hypercalciuria, osteoporosis, vertebral fracture, and reduced kidney function among the findings that can support operative management.

Closing paragraph
So what tests do you really need before deciding on parathyroid surgery? First, you need the right lab evaluation to establish whether the high calcium is truly coming from a parathyroid problem. After that, the decision is supported by the patient’s symptoms and by whether there is evidence that the disease is already affecting the kidneys or bones. In many cases, the diagnosis and the recommendation for surgery are already fairly clear from the labs and the overall clinical picture. Additional testing is often helpful, but it is most valuable for showing the impact of the disease and for clarifying borderline situations.

Disclaimer
This article is for general education only and is not personal medical advice. Individual recommendations depend on a patient’s history, laboratory findings, symptoms, imaging, and overall clinical situation.

Five Things to Know About Intraoperative PTH Monitoring

/in /by

1. Intraoperative PTH monitoring is a tool, not the whole operation.
Patients may hear a lot about intraoperative PTH monitoring and assume it is the main thing that makes parathyroid surgery successful. It is better thought of as one useful tool. The real goal of surgery is to identify and remove the overactive parathyroid gland or glands safely and effectively. Intraoperative PTH monitoring can help confirm that the right tissue has been removed, but it does not replace sound judgment and experience.

2. Some surgeons use it routinely, and some use it selectively.
This is one reason patients see so many different opinions online. Some surgeons check intraoperative PTH in nearly every case. Others use it in selected patients, such as when imaging is not clear, when more than one gland may be abnormal, or when the findings in the operating room are not straightforward. A surgeon’s approach often reflects training, experience, and how they structure their operation.

3. One advantage is that it gives real-time feedback.
Parathyroid hormone levels usually fall within 10-15 minutes after the overactive gland is removed. That means the surgeon can often get biochemical confirmation during the operation that the hyperparathyroidism has been corrected. This can be reassuring, especially in a focused operation where the surgeon is not planning to explore the entire neck.  It does take time to get the result back from the lab, typically 20-30 minutes after each blood sample is drawn. 

4. It also has limits.
Intraoperative PTH monitoring is not perfect. It adds steps to the procedure, will increase the time in the operating room, and sometimes the results are not completely straightforward. A falling PTH is helpful, but it still has to be interpreted in the context of the patient’s lab values, imaging, anatomy, and operative findings. It is an aid, not a guarantee. 

5. The important question is not simply whether it is used, but why.
Patients often ask whether intraoperative PTH monitoring is “the best way.” A better question is whether the surgeon has a clear plan and can explain why this tool is or is not being used in that particular case. Good parathyroid surgery is not defined by one single technique. It is defined by accurate diagnosis, thoughtful planning, careful surgery, and a high likelihood of cure.

Closing paragraph:
If you are talking with a surgeon about parathyroid surgery, it is reasonable to ask whether intraoperative PTH monitoring will be used and how it fits into the plan. The answer should make sense in the context of your case. Different surgeons may use different methods, but the goal is always the same: to treat the hyperparathyroidism safely and effectively.

Disclaimer:
This article is for general education only and is not personal medical advice. Individual recommendations depend on a patient’s full history, laboratory findings, imaging, and overall clinical situation.